Avik RoyVerified account

@Avik

President of the Foundation for Research on Equal Opportunity (). Policy Editor . Sr. Advisor . Pronounced "OH-vick" (thanks mom).

Austin, TX
freopp.org
Joined June 2009
253 Photos and videos Photos and videos

Tweets

You blocked @Avik

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @Avik

  1. Pinned Tweet
    Nov 2

    Let's use the next 4 years to build a new majority centered around what we once called liberalism: the centuries-old tradition of personal liberty, toleration, free enterprise, legal equality, and scientific inquiry; and a country in which everyone has the opportunity to succeed.

    Beginning the day after the election, we are convening some of the smartest and most creative people in the country to develop a unifying, policy agenda. Join us for the virtual conference!
    24 replies 48 retweets 276 likes
    Show this thread
    Show this thread
    Undo
  2. Dec 4

    For those who want "the best people" to come to America, we should celebrate the passage of the Fairness for High-Skilled Immigrants Act, which eliminates per-country quotas on skilled workers that effectively blocked U.S. immigration from a single country: India.

    Congrats to and the US Senate on unanimously passing the Fairness for High-Skilled Immigrants Act today. The below photo was taken in 2019 when introduced the legislation which ends country of origin discrimination and decade long wait times for greencards
    13 replies 23 retweets 150 likes
    Undo
  3. Retweeted
    Dec 1

    At FREOPP, we are working to ensure that more Americans can succeed, and that fewer are left behind. Today for , your generous donations will be matched up to $30,000. That means whatever you give today will be DOUBLED.

    2 retweets 3 likes
    Undo
  4. Retweeted
    Dec 1

    At FREOPP, we're working to ensure that more Americans can succeed and that fewer are left behind. Today for , your donations will be matched!

    2 retweets 1 like
    Undo
  5. Nov 26

    Mnuchin trying to kill the digital asset industry on his way out the door? If so, a boneheaded idea.

    Last week we heard rumors that the U.S. Treasury and Secretary Mnuchin were planning to rush out some new regulation regarding self-hosted crypto wallets before the end of his term. I'm concerned that this would have unintended side effects, and wanted to share those concerns.
    Show this thread
    1 reply 5 likes
    Undo
  6. Retweeted
    Nov 23

    the last time bitcoin was at this price, there was an insane frenzy of media requests and general inbound. it was torrential. this time pretty much nothing.

    46 replies 27 retweets 487 likes
    Show this thread
    Show this thread
    Undo
  7. Retweeted
    Nov 23

    This extensive article just published by the details our work at Libre, specifically our effort to engage and mobilize the Latino community in the fight to preserve a free society for generations to come.

    9 replies 26 retweets 83 likes
    Undo
  8. Nov 23

    Despite efforts by some to pooh-pooh the Danish study, the methodology was pretty solid. But its results are being incorrectly trumpeted by those who don't make a distinction between protective effect and source control.

    3 replies 3 retweets 18 likes
    Show this thread
    Show this thread
    Undo
  9. Nov 23

    The long-awaited Danish mask study () showed that mask mandates didn't meaningfully improve infection rates for the wearer (protective effect), but the study didn't look at spread from wearers to others (source control): a key virtue of good masks.

    3 replies 5 retweets 19 likes
    Show this thread
    Show this thread
    Undo
  10. Nov 23

    I agree with here. Not all masks are the same. N95s or equivalent are the gold standard. Standard cloth doesn't work. Also important (but not in Scott's op-ed): the primary reason to wear masks is to protect *others* if you're infected.

    Many Americans could take one simple step to protect themselves: Buy a better mask, writes
    8 replies 9 retweets 33 likes
    Show this thread
    Show this thread
    Undo
  11. Nov 21

    This. 👇

    It’s even more interesting than that, . This rift is between the ’s conservative and cronyist impulses. is abandoning conservatism’s limited-government principles in favor of cronyism, while is sticking up fir those principles.
    Show this thread
    1 reply 3 likes
    Undo
  12. Retweeted
    Nov 17

    If you are looking for a wonky description of why the improper payment rate is actually higher than what CMS is reporting, see here:

    1 retweet 3 likes
    Show this thread
    Show this thread
    Undo
  13. Retweeted
    Nov 17

    An improper payment rate in Medicaid of roughly 25% epitomizes government failure, on a massive scale, at the federal and state levels.

    1 reply 5 retweets 19 likes
    Show this thread
    Show this thread
    Undo
  14. Nov 20

    Really terrific to see take the helm of the Committee. Along with the Hospital Competition Act, Banks is a co-sponsor of the Fair Care Act of 2020, a plan to achieve market-based universal coverage:

    I know some people will be skeptical of this idea, but 's hospital competition bill is a good example of a fusion of new, populist-y instincts and market orthodoxy that would be good policy. I wrote about it in last year 1/3
    Show this thread
    1 reply 3 retweets 16 likes
    Undo
  15. Nov 20

    Finally, the Trump administration issued its rule ending PBM rebates in the Medicare Part D prescription drug program. This is also great policy, which will create stronger incentives for insurers & PBMs to reward lower drug prices. I explain :

    3 replies 13 retweets 42 likes
    Show this thread
    Show this thread
    Undo
  16. Nov 20

    I'm sure the drug industry will try to sue and block the interim final "most favored nation" rule, but it's likely to ultimately stand—and if for some reason it needs to be tweaked, the Biden administration can carry it forward. More info here:

    1 reply 2 retweets 17 likes
    Show this thread
    Show this thread
    Undo
  17. Nov 20

    I've written extensively at & about how Medicare's bizarre payment system *rewards* drug companies for charging higher prices, and pays doctors more money if they prescribe the costliest drug.

    2 replies 8 retweets 19 likes
    Show this thread
    Show this thread
    Undo
  18. Nov 20

    Which is why it's also terrific news that the Trump administration has finalized its "Most Favored Nation" rule enabling Medicare to get the same price as other countries get for physician-administered drugs. That's good for seniors & good for taxpayers.

    1 reply 6 retweets 29 likes
    Show this thread
    Show this thread
    Undo
  19. Nov 20

    Price exploitation of this kind is *rampant* in the pharmaceutical industry, and undermines claims that high prices are about innovation. In the U.S., companies price drugs as high as they can without garnering public blowback or payer resistance. It's not about R&D.

    2 replies 4 retweets 20 likes
    Show this thread
    Show this thread
    Undo
  20. Nov 20

    To give an example, colchicine, which was first developed to treat gout around 1500 B.C., had been on the market prior to the creation of the FDA. UDI created an artificial monopoly for one company, URL Pharma, which initiated a 5289% price increase and sold to Takeda for $800MM.

    3 replies 19 likes
    Show this thread
    Show this thread
    Undo
  21. Nov 20

    In my 2017 white paper on prescription drug reform (), I discussed the importance of ending the FDA's Unapproved Drugs Initiative, whose artificial government-created monopolies have led to price exploitation by drug companies. Trump ended it today.

    4 replies 36 retweets 89 likes
    Show this thread
    Show this thread
    Undo

@Avik hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·